These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The anemia of heart failure. Silverberg DS; Wexler D; Palazzuoli A; Iaina A; Schwartz D Acta Haematol; 2009; 122(2-3):109-19. PubMed ID: 19907148 [TBL] [Abstract][Full Text] [Related]
3. The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome. Silverberg DS Heart Fail Rev; 2011 Nov; 16(6):609-14. PubMed ID: 20865450 [TBL] [Abstract][Full Text] [Related]
4. The interaction between heart failure and other heart diseases, renal failure, and anemia. Silverberg DS; Wexler D; Iaina A; Schwartz D Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468 [TBL] [Abstract][Full Text] [Related]
5. [Anaemia in chronic heart failure]. Hradec J Vnitr Lek; 2010 Aug; 56(8):854-9. PubMed ID: 20845618 [TBL] [Abstract][Full Text] [Related]
6. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron? Silverberg DS; Wexler D; Iaina A J Nephrol; 2004; 17(6):749-61. PubMed ID: 15593047 [TBL] [Abstract][Full Text] [Related]
7. Future directions in management of anemia in heart failure. Agarwal AK; Katz SD Heart Fail Clin; 2010 Jul; 6(3):385-95. PubMed ID: 20630412 [TBL] [Abstract][Full Text] [Related]
8. Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anaemia syndrome. Palazzuoli A; Gallotta M; Iovine F; Nuti R; Silverberg DS Int J Clin Pract; 2008 Feb; 62(2):281-6. PubMed ID: 18081797 [TBL] [Abstract][Full Text] [Related]
9. The role of correction of anaemia in patients with congestive heart failure: a short review. Silverberg DS; Wexler D; Iaina A; Schwartz D Eur J Heart Fail; 2008 Sep; 10(9):819-23. PubMed ID: 18703380 [TBL] [Abstract][Full Text] [Related]
11. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060 [TBL] [Abstract][Full Text] [Related]
12. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178 [TBL] [Abstract][Full Text] [Related]
13. Role of iron deficiency and anemia in cardio-renal syndromes. Attanasio P; Ronco C; Anker SD; Cicoira M; von Haehling S Semin Nephrol; 2012 Jan; 32(1):57-62. PubMed ID: 22365163 [TBL] [Abstract][Full Text] [Related]
15. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. Toblli JE; Lombraña A; Duarte P; Di Gennaro F J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147 [TBL] [Abstract][Full Text] [Related]
16. Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure? Pagourelias ED; Koumaras C; Kakafika AI; Tziomalos K; Zorou PG; Athyros VG; Karagiannis A Angiology; 2009; 60(1):74-81. PubMed ID: 18413330 [TBL] [Abstract][Full Text] [Related]